8 Patents
- 0 cites
- US125903052026Complement Component C5 Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US125841302026Angiotensinogen (AGT) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US125036992025Compositions and Methods for Silencing Ugt1a1 Gene Expression
ALNYLAM PHARMACEUTICALS, Inc.
0 cites - US118734912024Complement Component C5 Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US118346612023Angiotensinogen (AGT) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - 0 cites
- 0 cites